SCHEMBL28625938

SCHEMBL28625938

OCc1cccc2c1ncn2CC(F)(F)F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP17A1 P05093 4/20 0.51
CYP1A2 P05177 1/20 0.51
ADORA2A P29274 1/20 0.38
ADORA1 P30542 1/20 0.38
AR P10275 3/20 0.35
KDM4E B2RXH2 1/20 0.34
LMNA P02545 1/20 0.34
TP53 P04637 1/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 1/20 0.34
ALOX12 P18054 1/20 0.34
FDPS P14324 1/20 0.34
NR1H4 Q96RI1 2/20 0.33
TLR7 Q9NYK1 1/20 0.33
CNR1 P21554 2/20 0.33
PDE5A O76074 1/20 0.33
PDE4A P27815 1/20 0.33
PDE1A P54750 1/20 0.33
PDE1B Q01064 1/20 0.33
PDE4B Q07343 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21555726 0.85 CYP17A1 (0.54) CYP17A1CYP1A2ADORA2AADORA1AR
SCHEMBL900219 0.80 CYP17A1 (0.71) CYP17A1CYP1A2KDM4ELMNATP53
SCHEMBL30119632 0.78 CYP17A1 (0.60) CYP17A1CYP1A2ADORA2AADORA1AR
SCHEMBL28645557 0.78 CYP17A1 (0.46) CYP17A1CYP1A2ADORA2AADORA1AR
SCHEMBL28626030 0.76 TLR7 (0.39) CYP17A1CYP1A2ARFDPSTLR7
SCHEMBL17596372 0.76 CYP11B1 (0.55) ADORA2ALMNANR1H4
SCHEMBL31363591 0.75 CYP17A1 (0.51) CYP17A1CYP1A2AR
SCHEMBL22533862 0.72 PKM (0.44) LMNANR1H4
SCHEMBL28634932 0.72 CYP17A1 (0.48) CYP17A1CYP1A2ARKDM4ELMNA
SCHEMBL3061771 0.72 DPP4 (0.44) KDM4ELMNATP53MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113429410-A Polyheterocyclic substituted pyrimidine or pyridylamine derivatives, compositions and medical uses thereof 上海海雁医药科技有限公司 2021-09-24 CN disclosed